Bi-fractionated oxaliplatin (L-OHP) plus 5-fluorouracil (5FU)/leucovorin (LV) for elderly patients (pts) with advanced colorectal cancer (CRC)

Cristian Massacesi,P. Lippe,F. Recchia,F. Marcucci,Marco Rocchi,A. Cesta,Alberta Pilone,C Cappelletti,M. Bonsignori,Rodolfo Mattioli

Bi-fractionated oxaliplatin (L-OHP) plus 5-fluorouracil (5FU)/leucovorin (LV) for elderly patients (pts) with advanced colorectal cancer (CRC)

2005

Cristian Massacesi
P. Lippe
F. Recchia
F. Marcucci
Marco Rocchi
A. Cesta
Alberta Pilone
C Cappelletti
M. Bonsignori
Rodolfo Mattioli

3619 Background: Delivering l-OHP over 2 days together with 5FU may enhance the synergism and reduce neurotoxicity. In this study we assessed activity, toxicity and both the activity of daily livin...

Keywords:

Fluorouracil
Oncology
Pathology
Colorectal cancer
5FU/Leucovorin
Oxaliplatin
Internal medicine
Medicine
Toxicity
Neurotoxicity
advanced colorectal cancer

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations